Patents by Inventor Huibing WANG

Huibing WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240014567
    Abstract: The present disclosure provides a wide beam radiation leakage coaxial cable, which includes an inner conductor, an insulating layer, an outer conductor and a sheath coaxially nested from inside to outside in sequence, at least two columns of slot groups are provided on the outer conductor, the columns of slot groups are distributed at different angles in the circumferential direction of the outer conductor, the included angle between two adjacent columns of slot groups is ?=?/n, where ? is the target radiation width, n is the number of columns of slot groups, each column of slot groups includes a plurality of slot arrays periodically arranged in the axial direction of the outer conductor, the pitch of each column of slot groups is the same, the pitch phase of each column of slot groups on the same leakage cable section is consistent, and each slot array includes a plurality of slots.
    Type: Application
    Filed: March 8, 2021
    Publication date: January 11, 2024
    Inventors: Haiyan SONG, Zhonghua LIU, Jianghua SHEN, Huibing WANG, Chao WU, Xuezi XU, Yi ZHOU, Cenjia LV, Lingfeng WANG, Yuanjing LI
  • Patent number: RE49851
    Abstract: The present invention relates to pyridinylaminopyrimidine derivatives represented by the following formula (I), and pharmaceutically acceptable salts, preparation process and use thereof, wherein R1, R2, R3, R4, R5, m and A are defined as in the description. Pyridinylaminopyrimidine derivatives of the present invention can selectively inhibit the activity of mutant-type epidermal growth factor receptor (EGFR), have a good inhibition for the cancer cell proliferation, and therefore can be used as a therapeutic agent for treating tumors and relevant diseases.
    Type: Grant
    Filed: July 15, 2021
    Date of Patent: February 27, 2024
    Assignee: Shanghai Allist Pharmaceuticals Co., Ltd.
    Inventors: Huibing Luo, Huayong Zhou, Shuhui Wang, Yong Wu